Arcus Biosciences, Inc.
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −0.72 USD per share, beating the −0.89 USD estimate by 19.21%. Revenue for the same period reached 41.00 M USD, despite the estimate of 21.98 M USD. For the next quarter, analysts expect −0.89 USD in earnings per share and 11.54 M USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise